Sign Out
Atrioventricular block of second or third degree; patients with unstable decompensated cardiac heart failure (pulmonary oedema, hypoperfusion or hypotension), and patients with continuous or intermittent inotropic therapy acting through β-receptor agonism; clinically relevant sinus bradycardia, sick-sinus syndrome, cardiogenic shock; severe peripheral arterial circulatory disorder.
Metoprolol should not be given to patients with suspected acute myocardial infarction as long as the heart rate is <45 beats/min, the P-Q interval is >0.24 sec or the systolic blood pressure is <100 mmHg.
Metoprolol CR (BETAZOK) is contra-indicated in patients who have shown hypersensitivity to any component of the product or to other β-blockers.
